| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |